中药对哮喘T细胞亚型免疫调节作用的研究进展  

Progress in Immuno-regulation of Chinese Medicine on T Cells Subsets in Asthma

作　　者：李航[1] 刘小虹[1] 徐卫方[2] LI Hang LIU Xiaohong XU Weifang(Guangzhou University of Chinese Medicine, Guangzhou 510405 Guangdong, China Shenzhen Hospital Affiliated to Guangzhou University of Chinese Medicine, Shenzhen 518034 Guangdong, China)

机构地区：[1]广州中医药大学,广东广州510405 [2]广州中医药大学深圳医院,广东深圳518034

出　　处：《中药新药与临床药理》2017年第1期132-136,共5页Traditional Chinese Drug Research and Clinical Pharmacology

基　　金：广东省中医药局项目(粤中医函[2015]102号)

摘　　要：哮喘是一种常见的慢性炎症性疾病,其发病机制已被证实依赖于T细胞的参与,特别是辅助性T细胞(Th1、Th2和Th17等)和调节性T细胞影响着哮喘的发生与发展。越来越多的研究证明中药(包括复方、单味药、单体)能通过调节T细胞免疫而发挥治疗哮喘的作用。本文对近年来在外文上发表的关于中药对哮喘T细胞亚型免疫调节作用的文献进行了综述,以期为中药治疗哮喘的研究提供参考。Asthma is one of the commonly-seen chronic inflammation diseases,and its mechanism has been verified to be dependent on the participation of T cells,especially on T helper cells（Th1,Th2 and Th17） and regulatory T cells.Nowadays more and more researches have proved Chinese medicine,including formula,single herb and monomers,has therapeutic effects on asthma through regulating T cells. This article reviewed the researches published in foreign language in recent years.

关 键 词：中药 哮喘 辅助性T细胞 调节性T细胞 免疫调节 综述 

分 类 号：R285.5[医药卫生—中药学]